News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
HHLR ADVISORS, LTD.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
SC 13D/A
| HHLR ADVISORS, LTD. reports a 8.3% stake in I-MAB |
| 08/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/27/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/19/2021 |
SC 13D/A
| HHLR ADVISORS, LTD. reports a 0% stake in Enstar Group Limited |
| 06/24/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/22/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/25/2021 |
SC 13D/A
| HHLR ADVISORS, LTD. reports a 11.3% stake in I-MAB |
| 12/21/2020 |
SC 13D/A
| HILLHOUSE CAPITAL ADVISORS, LTD. reports a 13.7% stake in I-MAB |
| 11/23/2020 |
SC 13D/A
| HILLHOUSE CAPITAL ADVISORS, LTD. reports a 7.6% stake in China Biologic Products Holdings, Inc. |
| 10/28/2020 |
SC 13D/A
| HILLHOUSE CAPITAL ADVISORS, LTD. reports a 7.7% stake in China Biologic Products Holdings, Inc. |
| 09/18/2020 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 7.7% stake in China Biologic Products Holdings, Inc. |
| 07/14/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/08/2020 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 7.7% stake in China Biologic Products Holdings, Inc. |
| 03/30/2020 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 1.2% stake in Cellular Biomedicine Group, Inc. |
| 02/21/2020 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 1.2% stake in Cellular Biomedicine Group, Inc. |
| 01/30/2020 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 1.2% stake in Cellular Biomedicine Group, Inc. |
| 01/27/2020 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 7.7% stake in China Biologic Products Holdings, Inc. |
| 04/02/2019 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 3% stake in Enstar Group Limited |
| 01/03/2019 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 8.2% stake in BeiGene, Ltd. |
|
|